计算溶液所需的质量、体积或浓度。
,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 7 篇同行评审文献引用。
Prostaglandin E2 (GMP) 是 GMP 级别的 Prostaglandin E2。GMP 级别的小分子可用做细胞疗法中的辅助试剂。Prostaglandin E2,一种炎症介质,是一种参与多种身体功能的内源性激素样物质。
Prostaglandin E2 (GMP) is a GMP grade Prostaglandin E2. GMP grade small molecules can be used as auxiliary reagents in cell therapy. Prostaglandin E2, An inflammatory mediator that is an endogenous hormone like substance involved in multiple bodily functions.
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 脂质和脂质样分子 |
| 类(Class) | 脂肪酰基 |
| 亚类(Subclass) | 二十烷酸 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 前列腺素及相关化合物 |
| 其他上位类(Alternative Parents) | 长链脂肪酸 羟基脂肪酸 不饱和脂肪酸 环戊醇 环酮 环状醇及其衍生物 一元羧酸及其衍生物 羧酸 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 脂肪族同单环化合物 |
| 取代基(Substituents) | 羟基苯甲酸酯 - 脂肪族同单环化合物 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 环醇 - 环酮 - 环戊醇 - 脂肪酸 - 烃衍生物 - 羟基脂肪酸 - 酮 - 长链脂肪酸 - 单羧酸或其衍生物 - 有机氧化物 - 有机氧化合物 - 有机氧化合物 - 前列腺素骨架 - 醛基 - 不饱和脂肪酸 |
| 描述(Description) | 该化合物属于前列腺素及相关化合物类有机化合物。这类不饱和羧酸由20个碳原子构成的骨架组成,其中包含一个五元环,其结构以脂肪酸花生四烯酸为基础。 |
| 外部描述符(External Descriptors) | Prostaglandins |
| ALogP | 2.8 |
|---|
| 1. Qi-Rui Hu, Qing-Xin Huang, Huan Hong, Yao Pan, Ting Luo, Jing Li, Ze-Yuan Deng, Fang Chen. (2023) Ginsenoside Rh2 and its octyl ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun/COX2/PGE2 pathway. PHYTOMEDICINE, [PMID:37806155] [10.1016/j.phymed.2023.155131] |
| 2. Mingrui Xiong, Hong Chen, Yu Fan, Muchuan Jin, Dong Yang, Yuchen Chen, Yu Zhang, Robert B. Petersen, Hua Su, Anlin Peng, Congyi Wang, Ling Zheng, Kun Huang. (2023) Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation. Theranostics, [PMID:37351176] [10.7150/thno.84308] |
| 3. Yongzhi Cui, Yuanyuan Guo, Li Kong, Jingyu Shi, Ping Liu, Rui Li, Yongtao Geng, Weihang Gao, Zhiping Zhang, Dehao Fu. (2021) A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioactive Materials, [PMID:34901540] [10.1016/j.bioactmat.2021.09.015] |
| 4. Jian Xiao, Shuqing Cao, Jiawei Wang, Pengyu Li, Quan Cheng, Xinyi Zhou, Jiacheng Dong, Yuan Li, Xinyu Zhao, Zekuan Xu, Li Yang. (2024) Leptin-mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer. Cancer Communications, [PMID:38958445] [10.1002/cac2.12583] |
| 5. Lei Yu, Bai Yaowei, Bai Xiatong, Sun Bo, Zhu Licheng, Wu Wenlong, Su Yang, Zhang Hongsen, Wang Yingliang, Zheng Chuansheng. (2025) COX-2/PGE2 axis blockade with celecoxib enhances anti-PD-1 efficacy by activating natural killer cells for residual hepatocellular carcinoma after radiofrequency ablation. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44 (1): (321). [PMID:41408296] [10.1186/s13046-025-03582-6] |
| 6. Guobin Li, Lan Zhang, Kaiting Ning, Baoqiang Yang, Francisca M. Acosta, Peng Shang, Jean X. Jiang, Huiyun Xu. (2021) Osteocytic Connexin43 Channels Regulate Bone–Muscle Crosstalk. Cells, 10 (2): (237). [PMID:33530465] [10.3390/cells10020237] |
| 7. Yuan Man-man, Zheng Bing-feng, Wang Jing-lin, Xu Shuai-qi, Wang Sheng-lan, Tan Yang, Feng Yong, Dong Xian-chi, Zhu Qi-hua, Yan Jie, Xu Qiang, Wu Xing-xin. (2026) Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGFβRII. ACTA PHARMACOLOGICA SINICA, [PMID:42533081] [10.1038/s41401-026-01878-7] |